German technology company CorTec implants second human with its brain-computer interface
Second implantation at Harborview Medical Center in Seattle marks continued progress in the FDA-approved study informed by promising results from the first participant. CorTec, a pioneer in active implantable medical technologies, has announced the “successful second implantation” of its proprietary Brain-Computer Interface (BCI) system, the Brain Interchange, in an FDA‑approved clinical trial involving stroke patients […]
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.